JuanPabloFriasMD
Endocrinology • Los Angeles, CADiabetes, Lipid Metabolism, Obesity
Medical Director and Principal Investigator, National Research Institute
Dr. Frias is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2010 Wilshire Blvd.
Suite 303
Los Angeles, CA 90057Phone+1 213-413-2500
Summary
- Dr. Juan Frias is an endocrinologist in Los Angeles, CA and is affiliated with VA San Diego Healthcare System. He received his medical degree from Vanderbilt University School of Medicine and has been in practice 28 years. He specializes in diabetes and lipid metabolism.
Education & Training
University of California (San Diego) Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1997 - 1999
University of TennesseeResidency, Internal Medicine, 1995 - 1997
Vanderbilt University Medical CenterResidency, Internal Medicine, 1994 - 1995
US Naval HospitalInternship, Internal Medicine, 1989 - 1990
Vanderbilt University School of MedicineClass of 1989
Certifications & Licensure
CA State Medical License 1997 - 2025
FL State Medical License 1991 - 2014
CO State Medical License 2001 - 2003
TN State Medical License 1995 - 1997
Awards, Honors, & Recognition
- Fellow (FACE) American Association of Clinical Endocrinology
Clinical Trials
- Glycemic Response to Road Cycling in Type 1 Diabetes Start of enrollment: 2011 May 01
- A Study to Evaluate BMS-986036 in Obese Adults With Type-2 Diabetes Start of enrollment: 2014 Apr 15
- A Study of LY2409021 in Participants With Type 2 Diabetes Mellitus Start of enrollment: 2014 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- 129 citationsFatty Acid-Induced Insulin Resistance: Decreased Muscle PI3K Activation But Unchanged Akt PhosphorylationYolanta T. Kruszynska, Dorothy Sears Worrall, Jachelle M. Ofrecio, Juan P. Frias, Gina Macaraeg
The Journal of Clinical Endocrinology and Metabolism. 2002-01-01 - 2 citationsClinical Characteristics and Glycemic Outcomes of Patients with Type 2 Diabetes Requiring Maximum Dose Insulin Glargine/Lixisenatide Fixed-Ratio Combination or Insulin...Lawrence Blonde, Timothy S. Bailey, Jason Chao, Terry Dex, Juan P. Frias
Advances in Therapy. 2019-07-29 - 16 citationsEfficacy and safety of insulin glargine/lixisenatide (iGlarLixi) fixed-ratio combination in older adults with type 2 diabetesYehuda Handelsman, Christina Chovanes, Terry Dex, Francesco Giorgino, Neil Skolnik
Journal of Diabetes and Its Complications. 2019-03-01
Press Mentions
Noninvasive Liver Screening Technology Enables Providers to Detect Liver Disease in Asymptomatic Patients, Identify at-Risk Patients for ReferralJune 9th, 2022- Echosens Underscores Impact of Obesity in Nonalcoholic Fatty Liver Disease & Metabolic Syndrome, Emphasizes Role of FibroScan to Monitor Liver Stiffness and Fat at Point-of-CareSeptember 15th, 2021
- SURPASS-3: Tirzepatide Superior to Basal Insulin for HbA1c, Body Weight ReductionAugust 10th, 2021
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
